-+ 0.00%
-+ 0.00%
-+ 0.00%
According to Zhitong Finance App, Baiyunshan (00874.HK) announced that Guangzhou Pharmaceutical Baiyunshan Hong Kong Co., Ltd. (“Baiyunshan Hong Kong”), a wholly-owned subsidiary of the company, plans to invest HK$350 million to pledge the limited partnership share of the Walbo Capital Health Limited Partnership Fund (“Asia Health Fund”), accounting for 35% of the fund after the fundraising is completed.
Share
Listen to the news
According to Zhitong Finance App, Baiyunshan (00874.HK) announced that Guangzhou Pharmaceutical Baiyunshan Hong Kong Co., Ltd. (“Baiyunshan Hong Kong”), a wholly-owned subsidiary of the company, plans to invest HK$350 million to pledge the limited partnership share of the Walbo Capital Health Limited Partnership Fund (“Asia Health Fund”), accounting for 35% of the fund after the fundraising is completed.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending